{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:24:26Z","timestamp":1780485866292,"version":"3.54.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Two vaccines expressing CD4+ and CD8+ T cell epitopes of melanoma-associated Ags (MAAs) by a chimpanzee-derived replication-defective AdC68 vector were compared in a mouse model of melanoma. In one vaccine, termed AdC68-gDMelapoly, the epitopes were expressed as a fusion protein within HSV-1 glycoprotein D (gD), which blocks immunoinhibitory signaling through the herpes virus entry mediator pathway. The other vaccine, termed AdC68-Melapoly, expressed only the MAA epitopes. AdC68-gDMelapoly induced more potent MAA-specific CD8+ T cell responses especially to the subdominant MAA epitopes. Upon prophylactic vaccination, mice that developed CD8+ T cell responses to the two vaccines that were comparable in magnitude showed equal protection against tumor challenge. When mice were first challenged with tumor cells and then vaccinated results differed. In animals with comparable CD8+ T cell responses, the AdC68-gDMelapoly vaccine was more efficacious compared with the AdC68-Melapoly vaccine in delaying tumor growth. This effect was linked to reduced expression of 2B4, LAG-3, and programmed death-1 on tumor-infiltrating MAA-specific CD8+ T cells elicited by the gD-adjuvanted vaccine, suggesting that CD8+ T cells induced in presence of gD are less susceptible to tumor-driven exhaustion.<\/jats:p>","DOI":"10.4049\/jimmunol.1302029","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T04:13:20Z","timestamp":1405397600000},"page":"1836-1846","source":"Crossref","is-referenced-by-count":21,"title":["The Effect of Adjuvanting Cancer Vaccines with Herpes Simplex Virus Glycoprotein D on Melanoma-Driven CD8+ T Cell Exhaustion"],"prefix":"10.1093","volume":"193","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[{"name":"Gene Therapy and Vaccines Program, University of Pennsylvania School of Medicine , Philadelphia, PA 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegund C J","family":"Ertl","sequence":"additional","affiliation":[{"name":"Gene Therapy and Vaccines Program, University of Pennsylvania School of Medicine , Philadelphia, PA 19104"},{"name":"Wistar Institute Vaccine Center, University of Pennsylvania , Philadelphia, PA 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,8,15]]},"reference":[{"key":"2025030707282017600_r1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/erv.09.144","article-title":"Mechanisms of T-cell inhibition: implications for cancer immunotherapy","volume":"9","author":"Mittendorf","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"2025030707282017600_r2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri1150","article-title":"Cancer vaccines: between the idea and the reality","volume":"3","author":"Finn","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"2025030707282017600_r3","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.4049\/jimmunol.1003682","article-title":"Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80","volume":"186","author":"Haile","year":"2011","journal-title":"J. Immunol."},{"key":"2025030707282017600_r4","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S1470-2045(11)70155-3","article-title":"Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?","volume":"13","author":"Jacobs","year":"2012","journal-title":"Lancet Oncol."},{"key":"2025030707282017600_r5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semcancer.2012.02.003","article-title":"Melanoma-induced immunosuppression and its neutralization","volume":"22","author":"Umansky","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"2025030707282017600_r6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00262-012-1327-0","article-title":"Increased prevalence of tumor-infiltrating regulatory T cells is closely related to their lower sensitivity to H2O2-induced apoptosis in gastric and esophageal cancer","volume":"62","author":"Izawa","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"2025030707282017600_r7","doi-asserted-by":"crossref","first-page":"e23661","DOI":"10.4161\/onci.23661","article-title":"Re-orienting the immune system: Durable tumor regression and successful re-induction therapy using anti-PD1 antibodies","volume":"2","author":"Lipson","year":"2013","journal-title":"OncoImmunology"},{"key":"2025030707282017600_r8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"2025030707282017600_r9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clindermatol.2012.08.006","article-title":"Immunomodulatory therapy for melanoma: ipilimumab and beyond","volume":"31","author":"Callahan","year":"2013","journal-title":"Clin. Dermatol."},{"key":"2025030707282017600_r10","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1158\/0008-5472.CAN-12-4100","article-title":"Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors","volume":"73","author":"Duraiswamy","year":"2013","journal-title":"Cancer Res."},{"key":"2025030707282017600_r11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1189\/jlb.1212621","article-title":"At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy","volume":"94","author":"Intlekofer","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"2025030707282017600_r12","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1128\/jvi.71.8.6083-6093.1997","article-title":"Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry","volume":"71","author":"Whitbeck","year":"1997","journal-title":"J. Virol."},{"key":"2025030707282017600_r13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-065X.2011.01064.x","article-title":"The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation","volume":"244","author":"Steinberg","year":"2011","journal-title":"Immunol. Rev."},{"key":"2025030707282017600_r14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-065X.2009.00783.x","article-title":"The CD160, BTLA, LIGHT\/HVEM pathway: a bidirectional switch regulating T-cell activation","volume":"229","author":"Cai","year":"2009","journal-title":"Immunol. Rev."},{"key":"2025030707282017600_r15","doi-asserted-by":"crossref","first-page":"11646","DOI":"10.1128\/JVI.01550-10","article-title":"Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition","volume":"84","author":"Stiles","year":"2010","journal-title":"J. Virol."},{"key":"2025030707282017600_r16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm1704","article-title":"Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses","volume":"14","author":"Lasaro","year":"2008","journal-title":"Nat. Med."},{"key":"2025030707282017600_r17","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.4049\/jimmunol.0903808","article-title":"Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathway","volume":"184","author":"DiMenna","year":"2010","journal-title":"J. Immunol."},{"key":"2025030707282017600_r18","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/mt.2011.88","article-title":"Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice","volume":"19","author":"Lasaro","year":"2011","journal-title":"Mol. Ther."},{"key":"2025030707282017600_r19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.152.2.381","article-title":"TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide","volume":"152","author":"Bacik","year":"1994","journal-title":"J. Immunol."},{"key":"2025030707282017600_r20","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1158\/0008-5472.CAN-06-4336","article-title":"Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitope","volume":"67","author":"Kianizad","year":"2007","journal-title":"Cancer Res."},{"key":"2025030707282017600_r21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"key":"2025030707282017600_r22","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1172\/JCI25591","article-title":"Optimization of a self antigen for presentation of multiple epitopes in cancer immunity","volume":"116","author":"Guevara-Pati\u00f1o","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2025030707282017600_r23","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.4049\/jimmunol.157.8.3242","article-title":"Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes","volume":"157","author":"Bergmann","year":"1996","journal-title":"J. Immunol."},{"key":"2025030707282017600_r24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0092-8674(91)90037-Y","article-title":"Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein","volume":"66","author":"Del Val","year":"1991","journal-title":"Cell"},{"key":"2025030707282017600_r25","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/nprot.2010.134","article-title":"An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector","volume":"5","author":"Zhou","year":"2010","journal-title":"Nat. Protoc."},{"key":"2025030707282017600_r26","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J. Virol."},{"key":"2025030707282017600_r27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"2025030707282017600_r28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2009.00784.x","article-title":"Mechanisms of costimulation","volume":"229","author":"Sharpe","year":"2009","journal-title":"Immunol. Rev."},{"key":"2025030707282017600_r29","first-page":"53","article-title":"The nature of activatory and tolerogenic dendritic cell-derived signal II","volume":"4","author":"de Vries","year":"2013","journal-title":"Front. Immunol."},{"key":"2025030707282017600_r30","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.4049\/jimmunol.172.10.5931","article-title":"An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection","volume":"172","author":"Han","year":"2004","journal-title":"J. Immunol."},{"key":"2025030707282017600_r31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol. Rev."},{"key":"2025030707282017600_r32","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"2025030707282017600_r33","doi-asserted-by":"crossref","first-page":"a011189","DOI":"10.1101\/cshperspect.a011189","article-title":"PI3K-PKB\/Akt pathway","volume":"4","author":"Hemmings","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2025030707282017600_r34","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bbrc.2003.11.070","article-title":"Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2","volume":"312","author":"Gavrieli","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025030707282017600_r35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/apt.12425","article-title":"Genetic risk factors for Clostridium difficile infection in ulcerative colitis","volume":"38","author":"Ananthakrishnan","year":"2013","journal-title":"Aliment Pharmacol. Ther."},{"key":"2025030707282017600_r36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.ejhg.5201527","article-title":"Haplotype analysis of tumour necrosis factor receptor genes in 1p36: no evidence for association with systemic lupus erythematosus","volume":"14","author":"Chadha","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"2025030707282017600_r37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/emm.2003.65","article-title":"High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases","volume":"35","author":"Jung","year":"2003","journal-title":"Exp. Mol. Med."},{"key":"2025030707282017600_r38","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1084\/jem.20071160","article-title":"A crucial role for HVEM and BTLA in preventing intestinal inflammation","volume":"205","author":"Steinberg","year":"2008","journal-title":"J. Exp. Med."},{"key":"2025030707282017600_r39","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/TP.0b013e3182339d4a","article-title":"B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity","volume":"92","author":"del Rio","year":"2011","journal-title":"Transplantation"},{"key":"2025030707282017600_r40","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1038\/sj.leu.2403175","article-title":"Stimulation of non-Hodgkin\u2019s lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity","volume":"17","author":"Costello","year":"2003","journal-title":"Leukemia"},{"key":"2025030707282017600_r41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1172\/JCI40070","article-title":"BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination","volume":"120","author":"Derr\u00e9","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2025030707282017600_r42","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1158\/0008-5472.CAN-11-2637","article-title":"CD8+ T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1","volume":"72","author":"Fourcade","year":"2012","journal-title":"Cancer Res."},{"key":"2025030707282017600_r43","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/COH.0b013e3282f9ae8b","article-title":"Programmed death-1 as a factor in immune exhaustion and activation in HIV infection","volume":"3","author":"Kaufmann","year":"2008","journal-title":"Curr. Opin. HIV AIDS"},{"key":"2025030707282017600_r44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.immunol.25.022106.141602","article-title":"Flying under the radar: the immunobiology of hepatitis C","volume":"25","author":"Dustin","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"2025030707282017600_r45","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1172\/JCI46102","article-title":"Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients","volume":"121","author":"Baitsch","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2025030707282017600_r46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.coi.2010.02.005","article-title":"Features of responding T cells in cancer and chronic infection","volume":"22","author":"Kim","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"2025030707282017600_r47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat. Immunol."},{"key":"2025030707282017600_r48","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"2025030707282017600_r49","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.4049\/jimmunol.181.7.4832","article-title":"NFATc1 regulates PD-1 expression upon T cell activation","volume":"181","author":"Oestreich","year":"2008","journal-title":"J. Immunol."},{"key":"2025030707282017600_r50","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1172\/JCI65325","article-title":"SHP-1 phosphatase activity counteracts increased T cell receptor affinity","volume":"123","author":"Hebeisen","year":"2013","journal-title":"J. Clin. Invest."},{"key":"2025030707282017600_r51","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4161\/onci.21285","article-title":"Functional differences between low- and high-affinity CD8+ T cells in the tumor environment","volume":"1","author":"Bos","year":"2012","journal-title":"OncoImmunology"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/193\/4\/1836\/61492667\/1302029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/193\/4\/1836\/61492667\/1302029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:53:54Z","timestamp":1741334034000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/193\/4\/1836\/7960165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1302029","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,8]]},"published":{"date-parts":[[2014,8]]}}}